Distinguished Attorney Timothy C. Moynahan Named Chairman of the Global Virus Network (Gvn) Board of Directors


Will Forge Partnerships With Multinational Corporations & Private Benefactors To Mitigate The Threat & Financial Impact Of Pandemic Viral Diseases

Baltimore, MD (December 17, 2013) – The Global Virus Network (GVN), a coalition of the world’s foremost medical virology research centers working to prevent illness and death from pandemic viruses, today announced that Timothy C. Moynahan, Esq., has been elected as the 2014 Chairman of the Board of Directors.  The announcement was made by Robert C. Gallo, MD, co-founder of the GVN, Chair of GVN’s Scientific Leadership Board, and Director of the Institute of Human Virology at the University of Maryland School of Medicine in Baltimore, Maryland, USA.  Dr. Gallo was joined in this announcement by GVN co-founders Reinhard Kurth, MD, Chairman of the Foundation Council, Ernst Schering Foundation in Berlin, Germany and William Hall, MD, PhD, Vice Chair of the GVN Board of Directors, and Director of the Centre for Research in Infectious Diseases the University College Dublin in Ireland.  Mr. Moynahan takes on the Chairman’s role from immediate past Chairman G. Steven Burrill, CEO of Burrill & Company.

“Mr. Moynahan brings a wealth of knowledge and expertise on international business and public-private sector partnerships to the GVN,” said Dr. Gallo, most notably known for his co-discovery of HIV and development of the blood test. “We are confident that Mr. Moynahan will lead the Board with vision  and passion for GVN’s critical mission of safeguarding life from potentially pandemic viral disease,” he added.   Mr. Moynahan served as the first Chairman of the GVN Board of Directors at the time of the GVN’s establishment in 2011.  “Tim’s insights into GVN as a founding Board member and as its inaugural Chairman position him perfectly to lead us successfully into the future,” continued Dr. Gallo.

One of Mr. Moynahan’s primary objectives is to develop partnerships with relevant multinational corporations and private benefactors in order to provide the substantial funding required to address the serious threat and exorbitant financial impact posed by potentially pandemic viral disease threatening public health.  “I am honored to serve as GVN’s Chairman once again and work alongside my dedicated and distinguished colleagues,” said Mr. Moynahan.  “Viruses continue to take tragic tolls on humanity in many ways, with millions of lives lost each year and staggering costs to the global economy.  The current flu season is a stark reminder:  According to the World Health Organization, seasonal flu in the United States alone results in 40,000 deaths and $87.1 billion in economic losses, both directly in terms of health care, and indirectly through work days lost and other factors.   One of my most important mandates is to raise awareness of the staggering impact of viruses on lives, commerce and businesses,” he added.

Mr. Moynahan, a preeminent litigation attorney, is the founder of The Moynahan Law Firm, one of Connecticut’s most respected law firms.   In addition to his role as Chairman of the Board of the Global Virus Network, Mr. Moynahan has been elected to the board of directors of numerous corporations and charitable organizations, including the Post University MBA Advisory Council, the Advisory Board of the Institute of Human Virology, the International Network for Cancer Treatment and Research (INCTR) and President of the Connecticut Chapter of the Ireland Chamber of Commerce in the United States.